The report below gives a good overview of the Summer 2025 M&A activity in the Healthcare & Life Sciences Industry Sector. The global healthcare services market is expected to reach $9.3 trillion in 2025 at a CAGR of 5.4% with medical advancements, growing healthcare coverage, and an aging population being the growth drivers. Fueled by the promotion of digital health use, health equity programs, and value-based care programs, the market is predicted to reach $11.2 trillion by 2029. The main trends influencing the future are the introduction of telemedicine, personalized and preventive care interventions, and healthcare integration within organizations to realize a higher level of efficiency and outcomes. Therapeutic areas like oncology, immunology, diabetes, obesity, and the pharma sector are set to lead through 2028. Alongside, the global market of life sciences is predicted to increase with a CAGR of 10.3% between 2025 and 2034, through the implementation of advanced technologies like artificial intelligence in the determination of medicines, CRISPR gene-editing therapy, and next-generation sequencing. It has a favorable market position that is influenced by the increasing chronic disease burdens and robust R&D pipelines. The United States ranks first in the life sciences industry, in terms of its developed healthcare infrastructure, the tremendous amounts of investments in biotechnology, and a center like the NIH (National Institutes of Health) accelerates the discovery of breakthroughs in the field of oncology, cardiology, and rare diseases.
Posted by David Sinyard.
Read the Entire Summer 2025 Healthcare & Life Sciences Report Here